3vm4
From Proteopedia
Jump to navigationJump to search
Cytochrome P450SP alpha (CYP152B1) in complex with (R)-ibuprophen
| ||||||||||||
Structural highlights
FunctionPublication Abstract from PubMedThe stereoselective epoxidation of styrene was catalyzed by H(2) O(2) -dependent cytochrome P450(SPalpha) in the presence of carboxylic acids as decoy molecules. The stereoselectivity of styrene oxide could be altered by the nature of the decoy molecules. In particular, the chirality at the alpha-positions of the decoy molecules induced a clear difference in the chirality of the product: (R)-ibuprofen enhanced the formation of (S)-styrene oxide, whereas (S)-ibuprofen preferentially afforded (R)-styrene oxide. The crystal structure of an (R)-ibuprofen-bound cytochrome P450(SPalpha) (resolution 1.9 A) revealed that the carboxylate group of (R)-ibuprofen served as an acid-base catalyst to initiate the epoxidation. A docking simulation of the binding of styrene in the active site of the (R)-ibuprofen-bound form suggested that the orientation of the vinyl group of styrene in the active site agreed with the formation of (S)-styrene oxide. Chiral-substrate-assisted stereoselective epoxidation catalyzed by H2O2-dependent cytochrome P450SPalpha.,Fujishiro T, Shoji O, Kawakami N, Watanabe T, Sugimoto H, Shiro Y, Watanabe Y Chem Asian J. 2012 Oct;7(10):2286-93. doi: 10.1002/asia.201200250. Epub 2012 Jun , 14. PMID:22700535[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References
| ||||||||||||||||||||
This page was last modified 12:26, 8 November 2023.